Literature DB >> 26341683

Central Dentinogenic Ghost Cell Tumor: An Update on a Rare Aggressive Odontogenic Tumor.

Amos Buchner1, Sharon J Akrish2, Marilena Vered3.   

Abstract

PURPOSE: Dentinogenic ghost cell tumor (DGCT) is a very rare odontogenic lesion, with most knowledge based on single case reports. Therefore, a comprehensive analysis was performed of the clinical and radiologic features of reported cases of DGCT with an emphasis on treatment modalities.
MATERIAL AND METHODS: This is a case series of DGCTs collected from the literature after a systematic search of Medline's PubMed and Google Scholar. Three additional cases were included from the authors' files. Demographic data of the patients, lesion site and size, and radiologic features were analyzed. Treatment approach and events of recurrence were recorded.
RESULTS: Forty-five cases (42 from the literature) were included. The mean age of patients was 39.7 ± 19.3 years (range, 12 to 79 yr) and the male-to-female ratio was 1.8:1. The mandible-to-maxilla ratio was 1.14:1, with the posterior region of the jaws being the most commonly involved site. Radiographically, 78% lesions were unilocular, 67% were mixed radiolucent and radiopaque, and 68% had well-defined borders. The mean lesion size was 4.0 cm (range, 1.8 to 13.0 cm). The primary treatment for 21 patients was conservative surgery consisting of enucleation or curettage. Follow-up information for longer than 1 year (mean, 6.2 ± 8.3 yr; range, 1 to 31 yr) was known for 15 patients, of whom 11 (73%) had recurrences. The primary treatment in 19 patients was radical surgery consisting of marginal or segmental resection. Follow-up information for longer than 1 year (mean, 3.3 ± 2.6 yr; range, 1 to 10 yr) was known for 12 patients, of whom 4 (33%) had recurrences.
CONCLUSIONS: This study highlighted the potentially aggressive biological behavior of DGCTs that demands extensive surgery and long follow-up. However, owing to the rarity of DGCT, more well-documented cases with long follow-up periods are needed to further define the optimal treatment modalities and prognosis.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26341683     DOI: 10.1016/j.joms.2015.08.001

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  6 in total

1.  Peripheral dentinogenic ghost cell tumor-report of two cases and review of the literature.

Authors:  Caio César da Silva Barros; Maurília Raquel de Souto Medeiros; Roberto Almeida de Azevedo; Márcia Cristina da Costa Miguel; Jean Nunes Dos Santos; Éricka Janine Dantas da Silveira
Journal:  Oral Maxillofac Surg       Date:  2021-02-14

Review 2.  Odontogenic tumors: where are we in 2017 ?

Authors:  John M Wright; Merva Soluk Tekkesin
Journal:  J Istanb Univ Fac Dent       Date:  2017-12-02

3.  Peripheral dentinogenic ghost cell tumor of the ethmoid sinus: A case report.

Authors:  Guo Liu; Jin-Nan Li; Feng Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

4.  Dentinogenic Ghost Cell Tumor in a Sumatran Rhinoceros.

Authors:  Annas Salleh; Zainal Z Zainuddin; Reza M M Tarmizi; Chee K Yap; Chian-Ren Jeng; Mohd Zamri-Saad
Journal:  Animals (Basel)       Date:  2021-04-20       Impact factor: 2.752

5.  Dentinogenic ghost cell tumor: Case report of a rare central variant and literature review.

Authors:  Vandana Reddy; Vijay Wadhwan; Roli Singh; Vishal Bansal
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

6.  Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic Review.

Authors:  Gustavo de Souza Vieira; Pâmella de Pinho Montovani; Rafaela Elvira Rozza-de-Menezes; Karin Soares Gonçalves Cunha; Danielle Castex Conde
Journal:  Head Neck Pathol       Date:  2021-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.